Indoco Remedies Files FY26 Business Responsibility and Sustainability Report

Indoco Remedies Ltd has submitted its Business Responsibility and Sustainability Reporting (BRSR) for the financial year 2025-2026, as per SEBI regulations. The report details the company's operations, including its primary business of manufacturing and sales of formulation pharmaceuticals, which accounts for 100% of its turnover. The company serves a diverse customer base globally, with exports contributing 45.10% of its total standalone revenue. The report also outlines employee details, with 5,038 employees and 1,517 workers, and highlights the representation of women in leadership roles.